Telaprevir for Chronic HCV Infection REPLY

被引：0
|
作者：
McHutchison, John [1 ]
Pawlotsky, Jean-Michel [2 ]
Zeuzem, Stefan [3 ]
机构：
[1] Duke Univ, Durham, NC 27715 USA
[2] Henri Mondor Univ Hosp, F-94010 Creteil, France
[3] JW Goethe Univ Hosp, D-60590 Frankfurt, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 05期
关键词：
HEPATITIS-C;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [1] Optimal treatment with telaprevir for chronic HCV infection
    Jesudian, Arun B.
    Jacobson, Ira M.
    LIVER INTERNATIONAL, 2013, 33 : 3 - 13
  • [2] Telaprevir for Previously Treated Chronic HCV Infection.
    McHutchison, John G.
    Manns, Michael P.
    Muir, Andrew J.
    Terrault, Norah A.
    Jacobson, Ira M.
    Afdhal, Nezam H.
    Heathcote, E. Jenny
    Zeuzem, Stefan
    Reesink, Hendrik W.
    Garg, Jyotsna
    Bsharat, Mohammad
    George, Shelley
    Kauffman, Robert S.
    Adda, Nathalie
    Di Bisceglie, Adrian M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (14): : 1292 - 1303
  • [3] Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
    Hezode, Christophe
    Forestier, Nicole
    Dusheiko, Geoffrey
    Ferenci, Peter
    Pol, Stanislas
    Goeser, Tobias
    Bronowicki, Jean-Pierre
    Bourliere, Marc
    Gharakhanian, Shahin
    Bengtsson, Leif
    McNair, Lindsay
    George, Shelley
    Kieffer, Tara
    Kwong, Ann
    Kauffman, Robert S.
    Alam, John
    Pawlotsky, Jean-Michel
    Zeuzem, Stefan
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18): : 1839 - 1850
  • [4] Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
    McHutchison, John G.
    Everson, Gregory T.
    Gordon, Stuart C.
    Jacobson, Ira M.
    Sulkowski, Mark
    Kauffman, Robert
    McNair, Lindsay
    Alam, John
    Muir, Andrew J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18): : 1827 - 1838
  • [5] Telaprevir for Retreatment of HCV Infection
    Zeuzem, Stefan
    Andreone, Pietro
    Pol, Stanislas
    Lawitz, Eric
    Diago, Moises
    Roberts, Stuart
    Focaccia, Roberto
    Younossi, Zobair
    Foster, Graham R.
    Horban, Andrzej
    Ferenci, Peter
    Nevens, Frederik
    Muellhaupt, Beat
    Pockros, Paul
    Terg, Ruben
    Shouval, Daniel
    van Hoek, Bart
    Weiland, Ola
    Van Heeswijk, Rolf
    De Meyer, Sandra
    Luo, Don
    Boogaerts, Griet
    Polo, Ramon
    Picchio, Gaston
    Beumont, Maria
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25): : 2417 - 2428
  • [6] Telaprevir combination therapy induced a sustained virologic response in nonresponsive chronic HCV infection
    Reichen, Juerg
    ANNALS OF INTERNAL MEDICINE, 2010, 153 (04)
  • [7] Telaprevir for Previously Treated Chronic HCV Infection (vol 362, pg 1292, 2010)
    McHutchison, J. G.
    Manns, M. P.
    Muir, A. J.
    Terrault, N. A.
    Jacobson, I. M.
    Afdhal, N. H.
    Heathcote, E. J.
    Zeuzem, S.
    Reesink, H. W.
    Garg, J.
    Bsharat, M.
    George, S.
    Kauffman, R. S.
    Adda, N.
    Di, Bisceglie A. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17): : 1647 - 1647
  • [8] Boceprevir for Chronic HCV Genotype 1 Infection REPLY
    Poordad, Fred
    Bacon, Bruce R.
    Brass, Clifford A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (02): : 177 - 178
  • [9] Eltrombopag for Thrombocytopenic Patients With Chronic HCV Infection Reply
    Afdhal, Nezam H.
    Theodore, Dickens
    GASTROENTEROLOGY, 2014, 147 (01) : 255 - 256
  • [10] Telaprevir for retreatment of HCV infection: review of the REALIZE trial
    Kim, Edward
    Chen, Yuan
    Yoshida, Eric M.
    FUTURE VIROLOGY, 2012, 7 (05) : 435 - 440
12345